Waters (WAT) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jul 04 2026 to Jun 28 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Waters Corporation  (NYSE: WAT)


Waters's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Waters's ROA in the second quarter of 2026?
Waters Corporation achieved a return on average assets (ROA) of 1.14 % in its second quarter of 2026, which is below Waters's average return on assets, which stands at 15.06%.

ROA decreased relative to the period ending Apr 04 2026, due to the decline in net income.

However, within the Healthcare sector 200 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 481 to 1260.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jul 04 2026)
II. Quarter		 (Apr 04 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 27 2025)
III. Quarter		 (Jun 28 2025)
II. Quarter
Y / Y Total Assets Change 433.38 % 419.3 % 11.55 % 40.35 % 36.51 %
Y / Y Net Income Change - - -1.74 % -7.79 % 3.06 %
Net Income (TTM) in million 166 449 643 647 659
Return On Assets (TTM) 1.14 % 4.73 % 13.51 % 13.98 % 15.4 %
WAT's Total Ranking # 1260 # 481 # 405 # 367 # 369
Total Assets (TTM) in million 24,751 23,451 5,080 4,788 4,640
Seq. Total Assets Change 5.54 % 361.67 % 6.08 % 3.19 % 2.76 %
Seq. Net Income Change - - 51.23 % 1.23 % 21.2 %

WAT's 5 Years Annual ROA >> Back to WAT Management Effectiveness >> Compare WAT ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 8
Sector # 201
Overall # 2141

Return On Assets Statistics
High Average Low
22.85 %
15.06 %
0.4 %
(Jun 30 2022)   (Dec 31 2017)





Financial Statements
Waters's Assets $ 24,751 million WAT's Balance sheet
Waters's Income $ -136 million Quarterly WAT's Income Statement
WAT's Income by Division See WAT's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 11.48 % 27.61 % 58.51 % -1.42 % 12.56 %
Total Assets in million 5,077 4,554 3,569 2,251 2,284
Y / Y Net Income Change 0.75 % -0.69 % -9.26 % 2.15 % 32.84 %
Net Income in million 643 638 642 708 693
Annual Return On Assets 12.66 % 14.01 % 18 % 31.44 % 30.34 %

WAT's 5 Years Annual ROA >> Back to WAT Management Effectiveness >> Compare WAT ROA to its Competitors



Comment on WAT's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA deteriorated to 12.66 %, despite annual net income growth of 0.75 % to $642.63 million, from $637.83 million a year ago, as WAT's assets increase to $5,076.55 million, by 0.75 %.


More Return On Assets Ratios
WAT's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
WAT's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for WAT's Competitors
Subscribers only: Roa for Waters's Suppliers
Subscribers only: Return On Assets for WAT's Customers

You may also want to know
WAT's Roi WAT's Inventory Turnover Ratio WAT's Growth Rates WAT's Dividend Comparisons
WAT's Profitability Ratios WAT's Asset Turnover Ratio WAT's Dividend Growth
WAT's Roe WAT's Valuation Ratios WAT's Financial Strength Ratios WAT's Dividend Payout Ratio



Companies with similar Return On Assets at Jul 04 2026, within Healthcare Sector ROA
Vaso Corporation  2.92 %
Collegium Pharmaceutical Inc   2.72 %
National Vision Holdings Inc   2.53 %
Conmed Corporation  2.44 %
Merck and Co Inc   2.42 %
Privia Health Group Inc   2.41 %
Lifestance Health Group Inc   2.33 %
Bio rad Laboratories Inc   2.21 %
Pfizer Inc  2.12 %
Mimedx Group Inc   1.99 %
Revvity Inc  1.97 %
Alkermes Plc   1.96 %
Becton Dickinson And Company  1.77 %
Teva Pharmaceutical Industries Limited  1.77 %
Immucell Corporation  1.76 %
Envista Holdings Corporation  1.69 %
Atricure Inc   1.62 %
Black Hawk Acquisition Corporation  1.56 %
Repligen Corp  1.41 %
Omada Health Inc   1.41 %
Arvinas Inc   1.29 %
Pacira Biosciences inc   1.17 %
Waters Corporation  1.12 %
Cormedix Inc   1.11 %
Warby Parker Inc   1.05 %
Surgery Partners Inc   1.02 %
Staar Surgical Co  0.84 %
Biomarin Pharmaceutical Inc  0.82 %
Icu Medical Inc  0.75 %
Lifemd Inc   0.65 %

Date modified: 2026-09-05T12:10:46+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.